Skip to main content
Molecular Oncology logoLink to Molecular Oncology
. 2019 Dec 5;14(1):230–231. doi: 10.1002/1878-0261.12604

Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition

Kara M Ruicci, Paul Plantinga, Nicole Pinto, Mohammed I Khan, William Stecho, Sandeep S Dhaliwal, John Yoo, Kevin Fung, Danielle MacNeil, Joe S Mymryk, John W Barrett, Christopher J Howlett, Anthony C Nichols
PMCID: PMC6944101  PMID: 31804024

In the original publication of this article, the RICTOR immunoblot in Fig. 4D was accidently removed as an error during production. The correct version of Fig. 4 is shown below.

Figure 4.

Figure 4

Deletion of RICTOR exon 5 disrupts the interaction between RICTOR and mTOR. (A) Schematic illustrating design of single‐guide RNA and primers for CRISPR/Cas9‐mediated deletion of exon 5 of RICTOR. (B) Predicted genotypes and base pair sizes for genomic PCR amplicons of RICTOR following CRISPR/Cas9 targeting of RICTOR. (C) Agarose gel images showing RICTOR amplicons in cell populations (FaDu, Cal27 cells) transfected with guides targeting RICTOR or an empty vector (PX458‐CMV). (D) Immunoblot of RICTOR expression in parental and mutant cell lines (E5‐XX lines). (E) Immunoblot showing co‐IP of RICTOR and mTOR in FaDu and Cal27 cells, but no detectable interaction in any of the putative RICTOR knockout cell lines.

Reference

  1. Ruicci KM, Plantinga P, Pinto N, Khan MI, Stecho W, Dhaliwal SS, Yoo J, Fung K, MacNeil D, Mymryk JS et al (2019) Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition. Mol Oncol 13, 2160–2177. 10.1002/1878-0261.12558 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Oncology are provided here courtesy of Wiley

RESOURCES